Skip to Main Content
Ronald S. Kaplan

Ronald S. Kaplan, PhD

Interim Director, Center for Genetic Diseases

 

  • Robert J. Bridges
    • Identification of potential drug candidates for the treatment of cystic fibrosis.
    • Probing human nasal epithelial cells for in vitropharmacogenomic studies for the treatment of cystic fibrosis.
  • Neil Bradbury
    • The regulation of membrane protein trafficking in cystic fibrosis.
    • Probing human nasal epithelial cells for in vitropharmacogenomic studies for the treatment of cystic fibrosis.
  • David M. Mueller
    • The structure and functional mechanism of the mitochondrial F1FO-ATPase. The structural basis for drugs and inhibitors that target the ATP synthase.
    • The structure and function of Cln3 - the gene defective in the juvenile form of Batten disease, a neurodegenerative disease of the brain.